MedTrace Logo

A Snapshot Study of Patients Affected by Gunshot Related Injuries in Trauma in South Africa

NCT03854591 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 138

Last updated 2021-04-28

No results posted yet for this study

Summary

Introduction- Gun violence represents an important cause of disability to the working age population in South Africa. It has unrecognised, but undoubtedly significant implications for the health service and patients affected by these injuries.

Aim- To capture the burden of gunshot injury across South Africa and to establish a network of researchers in this field.

Method- A cross-sectional observational study run across South Africa capturing a nationwide picture of burden and complications associated with these injuries. Each centre will participate in a two-week window of patient screening and recruitment. Patients will be followed up at 6 weeks as per routine clinical practice. Data collected will include nature and number of treatments, length of stay, return to work and complications.

Results-Outcome of the study will be disseminated to the participating centres, relevant health boards and published with all contributors across centres recognised.

Conditions

  • Trauma, Multiple
  • Gun Shot Wound

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • University of Oxford

    collaborator OTHER

  • University of Cape Town

    lead OTHER

Principal Investigators

  • Simon Graham, FRCS · Liverpool School of Hygiene and Tropical Medicine

  • Sithombo Maqungo, FCS · UCT

  • Michael Held, FCS · UCT

  • Maritz Laubscher, FCS · UCT

  • James Masters, MRCS · University of Oxford

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-18
Primary Completion
2019-05-08
Completion
2020-03-01

Countries

  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03854591 on ClinicalTrials.gov